2024
Outcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry.
Nguyen K, Altibi A, Prasad P, Mukundan S, Shekar K, Ramanathan K, Zakhary B. Outcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry. ASAIO Journal 2024 PMID: 38810234, DOI: 10.1097/mat.0000000000002243.Peer-Reviewed Original ResearchExtracorporeal membrane oxygenationVv-extracorporeal membrane oxygenationVenovenous extracorporeal membrane oxygenationExtracorporeal Life Support OrganizationMembrane oxygenationAdult patientsTreated with VV ECMOExtracorporeal Life Support Organization registryOutcomes of adult patientsFactors associated with conversionRisk factors associated with conversionIn-hospital mortality rateExtracorporeal membrane oxygenation configurationRenal replacement therapyLife Support OrganizationIn-hospital mortalityPrimary outcome measureRisk of mortalityRisk of conversionCOVID-19 patientsInotrope requirementPre-ECMOPropensity score matchingVA-ECMOInotropic agents
2018
Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis
Morra M, Van Thanh L, Kamel M, Ghazy A, Altibi A, Dat L, Thy T, Vuong N, Mostafa M, Ahmed S, Elabd S, Fathima S, Le Huy Vu T, Omrani A, Memish Z, Hirayama K, Huy N. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis. Reviews In Medical Virology 2018, 28: e1977. PMID: 29664167, PMCID: PMC7169085, DOI: 10.1002/rmv.1977.Peer-Reviewed Original ResearchConceptsChronic renal diseaseMiddle East respiratory syndromeRenal diseaseSupportive treatmentEfficacy of antiviral drugsAssociated with worse outcomesAntiviral drugsIFN-treated groupLarge-scale prospective randomized studiesProspective randomized studyMonitoring of adverse eventsRisk of mortalitySystematic literature searchOlder age groupsMiddle east respiratory syndrome patientsIFN groupCase fatality rateRandomized studyClinical outcomesAdverse eventsPreexisting comorbiditiesIFN treatmentWorse outcomesSystematic reviewTherapeutic efficacy